Oxford Biomedica Plc (OXBDF)
Oxford Biomedica Market Cap : 1.345B for Feb. 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Silence Therapeutics Plc | 226.72M |
| Adaptimmune Therapeutics Plc | 7.952M |
| Biodexa Pharmaceuticals Plc | 1.040M |
| NuCana Plc | 9.239M |
| Autolus Therapeutics Plc | 377.92M |
Market Cap Related Metrics
| PS Ratio | 6.064 |
| Price | 11.19 |
| Earnings Yield | -4.05% |